The Patent Finder

Libertas Bio, Inc.

10 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Abs Development 1, Inc. (to 2023)

0
Ending by 2030
Feb 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 2, 2026
    The maintenance fee for Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis (US 9,044,482) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
  • 1 fee due May 10, 2027
    The maintenance fee for Cyclohexylamines (US 9,180,115) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Pyrimido-Pyridazinone Compounds and Methods of Use Thereof (US 10,647,720) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 8,865,741Aminoindane Compounds and Use Thereof in Treating Pain
In force
 · High confidence
In forceHigh confidence
US 9,375,423Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis
In force
 · High confidence
In forceHigh confidence
US 9,382,277Pyrimido-Pyridazinone Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 10,183,944Pyrimido-Pyridazinone Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 10,647,720Pyrimido-Pyridazinone Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 8,729,079Pyrimido-Pyridazinone Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 9,180,115Cyclohexylamines
In force
 · Medium confidence
In forceMedium confidence
US 9,044,482Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis
In force
 · High confidence
In forceHigh confidence
US 10,188,654Uses of pyrimido-pyridazinones to treat cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,036,224Formulations, Methods, Kits, and Dosage Forms for Treating Atopic Dermatitis and for Improved Stability of an Active Pharmaceutical Ingredient
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 10: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited